SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-24-006918
Filing Date
2024-02-15
Accepted
2024-02-15 21:01:03
Documents
3
Period of Report
2024-01-24

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 2202
2 ex24.htm EX-24 988
3 ex24_001.jpg GRAPHIC 325125
  Complete submission text file 0001493152-24-006918.txt   452667
Mailing Address 455 E. MEDICAL CENTER BLVD SUITE 300 SUITE 300 HOUSTON TX 77598
Business Address 455 E. MEDICAL CENTER BLVD SUITE 300 HOUSTON TX 77598 281-671-5152
FibroBiologics, Inc. (Issuer) CIK: 0001958777 (see all company filings)

IRS No.: 863329066 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1651 NORTH BEVERLY DRIVE BEVERLY HILLS CA 90210
Business Address
Niklas Victoria Ninon Olivia (Reporting) CIK: 0002012250 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41934 | Film No.: 24645585